Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Lymphoplasmacytic Lymphoma
Related studies linked through entity extraction aliases.
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
Watch and Wait or Worry and Wait in Indolent Lymphoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
- Status
- RECRUITING
- Phase
- NA
64Cu-LLP2A for Imaging Hematologic Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Study of SGR-1505 in Mature B-Cell Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL
- Status
- WITHDRAWN
- Phase
- PHASE1
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
- Status
- COMPLETED
- Phase
- PHASE1
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1